Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05866952 · ClinicalTrials.gov registry record
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
A clinical trial of Dyspnea and Post-Acute COVID-19, sponsored by Tufts Medical Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05866952 is a study of Dyspnea and Post-Acute COVID-19 that is actively recruiting participants, run by Tufts Medical Center. The registered enrollment target is 40 participants, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05866952, a study of Dyspnea and Post-Acute COVID-19, is actively recruiting participants, sponsored by Tufts Medical Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Computed Tomography of the Chest
Study Locations (1)
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-06-05 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05866952
The ClinicalTrials.gov registry entry for NCT05866952 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (87% lower). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which Computed Tomography of the Chest is the first listed.
NCT05866952 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05866952 about?
NCT05866952 is a clinical study titled "Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection". Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations
What is the current status of trial NCT05866952?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-06-05. Estimated completion is 2026-12-31.
What conditions does trial NCT05866952 study?
This clinical trial studies the following conditions: Dyspnea, Post-Acute COVID-19, Post COVID-19 Condition, Post Viral Fatigue.
What interventions are being tested in trial NCT05866952?
The interventions under investigation include: Computed Tomography of the Chest (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05866952?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05866952 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
-
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.